Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BRONALIDE INHAL 250MCG/AEM DIN 00790486

Status: Cancelled Post Market
Holder: BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Molecule: FLUNISOLIDE

Health Canada record

Active ingredient(s)FLUNISOLIDE 250 MCG
Dosage formMetered-Dose Aerosol
RouteInhalation
SchedulePRESCRIPTION
ClassHuman
ATCR03BA03 FLUNISOLIDE
Original market date31-Dec-1988
Current status date15-Feb-1999
SourceHealth Canada DPD

Establishment licence of the holder

Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing FLUNISOLIDE

DINProductCompanyFormStrengthStatus
02239288APO-FLUNISOLIDE NASAL SPRAYAPOTEX INCMetered-Dose PumpFLUNISOLIDE 0.25 MGCancelled Post Market
02230306NOVO-FLUNISOLIDENOVOPHARM LIMITEDSprayFLUNISOLIDE 25 MCGCancelled Post Market
01927167PMS-FLUNISOLIDEPHARMASCIENCE INCSprayFLUNISOLIDE 0.025 %Cancelled Post Market
00878790RATIO-FLUNISOLIDERATIOPHARM INC DIVISION OF TEVA CANADA LIMITEDSprayFLUNISOLIDE 25 MCGCancelled Post Market
02162687RHINALAR NASAL MISTIVAX LABORATORIES INCORPORATEDSpray; SolutionFLUNISOLIDE 25 MCGCancelled Post Market

International API supply for FLUNISOLIDE

5 active FDA Drug Master Files.

Request a quote for BRONALIDE INHAL 250MCG/AEM

How to read a Canadian DIN record